Design Therapeutics, Inc.

NASDAQ:DSGN

Biotechnology

Healthcare
$9.47 +1.59%

+$0.19 today

Market cap
$606.42M
Beta
1.66
P/E (TTM)
-10.7
EPS (TTM)
-$1.13
52W Low $3.33High $17.25

Volume 0.32M

Average 0.74M

DSGN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Design Therapeutics, Inc.NASDAQ: DSGN

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 61.43M shares rose 8.2% year over year, ahead of the +2.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 7.2% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +8.2% holds above the trailing-twelve-month pace of +2.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
61.43M+7.2% QoQ
Last fiscal yearDec 2025
57.33M+1.3% YoY
LTMMar 2026
58.14M+2.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.2%——
1 year+1.3%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
57.33M USD
Year-over-year change
+1.3%
4-year CAGR
+5.7%

Weighted Avg Shares (Diluted) vs competitors

How DSGN compares with its peers on the latest reported figures

  • DSGN's LTM Mar 2026 weighted avg shares (diluted) of 58.14M shares is the 10th highest of the 11 companies compared; the peer median is 91.93M shares.
  • Its year-over-year change of +2.6% is the 10th highest of 11, against a peer median of +12.1%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +21.9%.
DSGN Competitors Peer median
Weighted Avg Shares (Diluted) for DSGN and competitors
Company Period LTM YoY 3-year CAGR
WVEWave Life Sciences Ltd.LTM Mar 2026178.01M +19.3%+28.8%
IONSIonis Pharmaceuticals, Inc.LTM Sep 2026164.62M -0.2%+4.1%
DYNDyne Therapeutics, Inc.LTM Jun 2026150.19M +40.8%+35.2%
SRPTSarepta Therapeutics, Inc.LTM Mar 2026108.39M +6.9%+6.2%
SLDBSolid Biosciences Inc.LTM Mar 202698.28M +94.3%+117.4%
PTCTPTC Therapeutics, Inc.LTM Jun 202685.59M +7.4%+7.2%
LRMRLarimar Therapeutics, Inc.LTM Mar 202678.18M +22.5%+41.5%
FULCFulcrum Therapeutics, Inc.LTM Mar 202666.18M +9.2%+12.1%
STOKStoke Therapeutics, Inc.LTM Mar 202659.6M +4.3%+15.0%
DSGNDesign Therapeutics, Inc.LTM Mar 202658.14M +2.6%+1.0%
PEPGPepGen Inc.LTM Mar 202637.49M +15.0%+39.2%
Peer median (excluding DSGN) 91.93M+12.1%+21.9%

Competitors are the stored peer set for DSGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue0466K537K596K622K
Gross Profit0(466K)(537K)(596K)(622K)
Gross Margin—————
Research & Development24.78M48.61M57.06M44.35M59.13M
Selling, General & Admin11.05M18.98M21.13M18.03M20.34M
Operating Expenses35.83M67.13M77.65M61.79M78.85M
Depreciation & Amortization129K466K537K596K622K
EBITDA(35.4M)(62.84M)(66.33M)(48.99M)(69.17M)
EBITDA Margin—————
Operating Income(35.83M)(67.59M)(78.19M)(62.38M)(79.47M)
Operating Margin—————
Interest Income00012.8M9.68M
Interest Expense00000
Other Income / Expenses298K4.29M11.33M12.8M9.68M
Income Before Tax(35.53M)(63.31M)(66.86M)(49.59M)(69.79M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(35.53M)(63.31M)(66.86M)(49.59M)(69.79M)
Net Margin—————
EPS (Basic)(0.77)(1.14)(1.19)(0.88)(1.22)
EPS (Diluted)(0.77)(1.14)(1.19)(0.88)(1.22)
Weighted Avg Shares45.94M55.71M55.98M56.59M57.33M
Weighted Avg Shares (Diluted)45.94M55.71M55.98M56.59M57.33M

Design Therapeutics, Inc.

NASDAQ:DSGN

Intrinsic Alpha fair value

Locked

Current Price

$9.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.